What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review

Código QR

What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review

With prevalence high and rising given the close relationship with obesity and diabetes mellitus, non-alcoholic fatty liver disease (NAFLD) is progressively becoming the most common chronic liver condition worldwide. However, little is known about the health inequalities in NAFLD distribution and out...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mar Talens, Natalia Tumas, Jeffrey V. Lazarus, Joan Benach, Juan M. Pericàs
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	non-alcoholic fatty liver disease health inequalities social determinants of health Medicine R
Acceso en línea:	https://doaj.org/article/a42c00b753864be7acc2cd161357fbaf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Local Inequalities in Health Behaviours: Longitudinal Findings from the Stockton-On-Tees Cohort Study
por: Nasima Akhter, et al.
Publicado: (2021)

Editorial: New Insights Into Understanding and Managing NAFLD
por: Óscar Escribano, et al.
Publicado: (2021)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
por: Pegah Golabi, et al.
Publicado: (2022)

A new generalized refinements of Young’s inequality
por: Ighachane,Mohamed Amine, et al.
Publicado: (2021)

NAFLD in the Elderly
por: Alqahtani SA, et al.
Publicado: (2021)

Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
por: Junli Liu, et al.
Publicado: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Daniela Maria Tanase, et al.
Publicado: (2021)

Health Inequality Analysis in Europe: Exploring the Potential of the EQ-5D as Outcome
por: Inge Spronk, et al.
Publicado: (2021)

Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population
por: Magda Shaheen, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
por: Sue Shea, et al.
Publicado: (2021)

Intra-territorial inequalities in children’s hospital admissions in the Metropolitan area of Santiago, Chile
por: Manuel Fuenzalida, et al.
Publicado: (2018)

Rol de la microbiota intestinal en el desarrollo del hígado graso no alcohólico
por: Tumani,María Fernanda, et al.
Publicado: (2021)

Análisis crítico del tratamiento de la enfermedad hepática grasa no alcohólica
por: Lanuza,Fabian, et al.
Publicado: (2018)

Effect of Long-Term Exercise on Liver Lipid Metabolism in Chinese Patients With NAFLD: A Systematic Review and Meta-Analysis
por: Ye Gao, et al.
Publicado: (2021)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
por: N. V. Mikhaylova, et al.
Publicado: (2019)

Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
por: Shuiqing Lai, et al.
Publicado: (2021)

Non-invasive Diagnostics of Liver Fibrosis
por: Mihaylov R., et al.
Publicado: (2017)

The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
por: Mai BH, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
por: Cosmas Rinaldi Adithya Lesmana, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
por: Tetiana Ranhulova
Publicado: (2021)

The longer-term effects of human capital enrichment programs on poverty and inequality: Oportunidades in Mexico
por: McKee,Douglas, et al.
Publicado: (2011)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
por: Zhi-Qin Xie, et al.
Publicado: (2021)

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
por: Aleksandr E. Nosov, et al.
Publicado: (2021)

Cytoprotective and suicidal signaling in oxidative stress
por: Videla,Luis A
Publicado: (2010)

<i>“It Is Like We Are Living in a Different World”</i>: Health Inequity in Communities Surrounding Industrial Mining Sites in Burkina Faso, Mozambique, and Tanzania
por: Andrea Leuenberger, et al.
Publicado: (2021)

Learning our lesson: using past policies to improve digital and ethnic inequalities beyond the pandemic
por: Mel Ramasawmy, et al.
Publicado: (2021)

Alteraciones de la tolerancia a la glucosa y frecuencia de síndrome metabólico en pacientes con enfermedad por hígado graso no alcohólico
por: Araya Q,A. Verónica, et al.
Publicado: (2006)

The Islamic tradition and health inequities: A preliminary conceptual model based on a systematic literature review of Muslim health-care disparities
por: Aasim I. Padela, et al.
Publicado: (2018)

“Nobody Seems to Know Where to Even Turn To”: Barriers in Accessing and Utilising Dementia Care Services in England and The Netherlands
por: Clarissa Giebel, et al.
Publicado: (2021)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
por: Ana Šinkovec, et al.
Publicado: (2021)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Satoru Hagiwara, et al.
Publicado: (2021)

Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity
por: Yu-Tang Tung, et al.
Publicado: (2021)

Identifying High-Risk NASH Patients: What We Know so Far
por: Schulz M, et al.
Publicado: (2020)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Michael T. Osterholm, et al.
Publicado: (2015)

Public spending and the poor: what we know, what we need to know
por: Van de Walle, Dominique
Publicado: (2014)

Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
por: Nooshin Ghodsian, et al.
Publicado: (2021)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
por: Rayvita AN Meagratia, et al.
Publicado: (2021)

Blancos terapéuticos potenciales para revertir la cirrosis hepática
por: García B,Leonel, et al.
Publicado: (2007)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
por: Aleksandr I. Pavlov, et al.
Publicado: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar R, et al.
Publicado: (2018)